Literature DB >> 3166023

Prepubertal male pseudohermaphroditism due to 17-ketosteroid reductase deficiency: diagnostic value of a hCG test and lack of HLA association.

I J Arnhold1, B B Mendonça, J A Diaz, C Nogueira, M C Batista, G Madureira, D Oliveira, W Nicolau, W Bloise.   

Abstract

Most patients with male pseudohermaphroditism (MPH) due to 17-ketosteroid reductase (17-KSR) deficiency were diagnosed at or after puberty when significant virilization occurred. We report 2 prepubertal sibs (Case 1, 4 yr and Case 2, 10 yr) unambiguously raised as females, with clitoral enlargement, separate urethral and vaginal orifices and gonads palpable at the inguinal canal bilaterally. Basal serum LH, FSH, 17-hydroxyprogesterone, testosterone (T), dihydrotestosterone and dehydroepiandrosterone (DHEA) were normal for age. delta 4-Androstenedione (delta 4-A) was slightly elevated in Case 2 but nondiagnostic. Steroid measurements after human chorionic gonadotropin (hCG) stimulation were compared with those of boys with male external genitalia submitted to the same hCG protocol: peak T was subnormal (Case 1, 80, Case 2, 91, vs normal 329 +/- 129 ng/dl, mean +/- 1SD), peak delta 4-A elevated (Case 1, 477, Case 2, 264, vs normal 44 +/- 26 ng/dl) resulting in an abnormally elevated delta 4-A/T ratio (Case 1, 6.0, Case 2, 2.9, vs normal 0.12 +/- 0.09) and establishing the diagnosis of 17-KSR deficiency. This diagnosis was confirmed in vitro by minimal T production when testicular tissue of both patients was incubated with tritiated delta 4-A. The 2 sibs did not share a single haplotype for the HLA complex indicating lack of association between HLA and the locus of the gene for 17-KSR. In conclusion, in 2 sibs with MPH the subnormal T and elevated delta 4-A response to the hCG test indicated the diagnosis of 17-KSR deficiency followed by orchiectomy to avoid later virilization at puberty.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166023     DOI: 10.1007/BF03350158

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Proceedings: 17beta-hydroxysteroid oxidoreductase deficiency causing male pseudohermaphroditism in a child.

Authors:  R A Harkness; D Thistlethwaite; J A Darling; N E Skakkebaek; C S Corker
Journal:  J Endocrinol       Date:  1975-11       Impact factor: 4.286

2.  Familial male pseudohermaphroditism without gynecomastia due to deficient testicular 17-ketosteroid reductase activity.

Authors:  J R Givens; W L Wiser; R L Summitt; I J Kerber; R N Andersen; D E Pittaway; S A Fish
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

3.  Further in vivo studies in male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect (compared to a case of testicular feminization).

Authors:  J M Saez; A M Morera; E De Peretti; J Bertrand
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

4.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

5.  Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: gender reassignment in early infancy.

Authors:  D J Gross; H Landau; G Kohn; A Farkas; E Elrayyes; R el-Shawwa; E E Lasch; A Rösler
Journal:  Acta Endocrinol (Copenh)       Date:  1986-06

6.  [Familial case of male pseudohermaphroditism due to 17-ketoreductase defect: late diagnosis in the "aunt" of a patient with the same defect (author's transl)].

Authors:  M G Forest; E de Peretti; A Campo-Paysaa
Journal:  Ann Endocrinol (Paris)       Date:  1979       Impact factor: 2.478

7.  In vitro steroid metabolic studies in testicular 17 beta-reduction deficiency.

Authors:  U Goebelsmann; T D Hall; W L Paul; F Z Stanczyk
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

8.  Familial male pseudohermaphroditism with gynaecomastia due to 17 beta-hydroxysteroid dehydrogenase deficiency. A report of 3 cases.

Authors:  R Balducci; V Toscano; F Wright; F Bozzolan; G Di Piero; M Maroder; P Panei; F Sciarra; B Boscherini
Journal:  Clin Endocrinol (Oxf)       Date:  1985-10       Impact factor: 3.478

9.  Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role.

Authors:  A Rösler; G Kohn
Journal:  J Steroid Biochem       Date:  1983-07       Impact factor: 4.292

10.  Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty.

Authors:  J Imperato-McGinley; R E Peterson; R Stoller; W E Goodwin
Journal:  J Clin Endocrinol Metab       Date:  1979-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.